Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270391
Max Phase: Preclinical
Molecular Formula: C10H19N5O2
Molecular Weight: 241.29
Associated Items:
ID: ALA5270391
Max Phase: Preclinical
Molecular Formula: C10H19N5O2
Molecular Weight: 241.29
Associated Items:
Canonical SMILES: CCCCNc1nc(N)nnc1OCCOC
Standard InChI: InChI=1S/C10H19N5O2/c1-3-4-5-12-8-9(17-7-6-16-2)14-15-10(11)13-8/h3-7H2,1-2H3,(H3,11,12,13,15)
Standard InChI Key: VIHBVDINDVCXES-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 241.29 | Molecular Weight (Monoisotopic): 241.1539 | AlogP: 0.69 | #Rotatable Bonds: 8 |
Polar Surface Area: 95.18 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.97 | CX LogP: 0.70 | CX LogD: 0.70 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.65 | Np Likeness Score: -1.33 |
1. Kaushik D, Kaur A, Petrovsky N, Salunke DB.. (2021) Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles., 12 (7.0): [PMID:34355178] [10.1039/D1MD00031D] |
Source(1):